Scilex Holding Co
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Palo Alto, CA
SCLX chart
What traders are saying about $SCLX
Latest postsScilex Holding Co news
- Scilex Holding Company Estimates – NASDAQ:SCLXW
TradingView ·
- Top Scilex (SCLX) Competitors 2026
MarketBeat ·
- DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
The Courier-Journal ·
- Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.
Yahoo Finance ·
- Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
Yahoo Finance ·
- Scilex, Vera Therapeutics rise premarket; Strategy gains
Yahoo Finance ·
- Scilex Shares Jump After Securing $100 Million Strategic Investment Proposal (SCLX)
investorshub.advfn.com ·
- Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
Yahoo Finance ·
- ZTlido Emerges as Top Non-Opioid Pain Therapy: Market Expansion and Physician Adoption Insights
Yahoo Finance ·
- Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
Yahoo Finance ·
- Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
Yahoo Finance ·
- Scilex Holding Company (“Scilex”) Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
Yahoo Finance ·
Scilex Holding Co key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $30.3M | $56.6M | $46.7M | $38.0M |
| Net income | -$374.1M | -$72.8M | -$114.3M | -$23.4M |
| Diluted EPS | $-36.48 | $-8.05 | $-1.28 | $-0.17 |
| Total assets (year end) | $365.0M | $93.0M | $101.3M | $86.5M |
| Cash and equivalents (year end) | $5.0M | $3.3M | $3.9M | $2.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Scilex Holding Co
- Ticker
- SCLX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Palo Alto, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1820190
- Former names
- Scilex Holding Company/DE, Vickers Vantage Corp. I
Frequently asked questions
What exchange is Scilex Holding Co listed on?
Scilex Holding Co trades on the Nasdaq under the ticker symbol SCLX.
What industry is Scilex Holding Co in?
Scilex Holding Co is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Scilex Holding Co headquartered?
Scilex Holding Co's business address on file with the SEC is in Palo Alto, CA.
When does Scilex Holding Co's fiscal year end?
Scilex Holding Co's fiscal year ends on December 31.
How much revenue did Scilex Holding Co report?
Scilex Holding Co reported $30.3M in revenue for calendar year 2025, according to its SEC filings.